Latest news with #AbhayAgarwal
Economic Times
2 days ago
- Business
- Economic Times
We are in a sell-on-rise market; accumulate Paytm and Nykaa for long-term gains: CA Rudramurthy BV
Live Events You Might Also Like: Biggest positive trigger for markets would be a sustainable resolution of tariff issue: Abhay Agarwal (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel , MD,says till we cross 56,000 for Bank Nifty and 24,800 for Nifty, this will remain a sell-on- rise market. This is a good time for long-term investors. Paytm and Nykaa stocks are recommended for portfolio inclusion. Accumulate Paytm around current levels, targeting Rs 1,350-1,500. Nykaa is also a strong buy at the current price. Investors can accumulate on dips, targeting Rs 245-250. These targets are expected within six months to one year. Risk-reward favors buying these new-age stocks Sell-on-rise is a simple strategy which the market is holding on to and even as for Nifty, on 12th of May, 24,350 was a very, very crucial support for Nifty. Yesterday, we went to those levels and saw a bounce, but that bounce was more to do with a short covering that we saw because of an expiry day and now we are again back to lower levels and the market is definitely a sell on rise for a very short we break the 24,350 level, further lower levels closer to 24,000 and then even 23,800 is possible. The market is more sector and stock specific, but we should definitely accept that it is a sell-on-rise market and even though FIIs are short over 90%, there is still no respite whatsoever and unless we get a trigger – either the Trump tariff ending and Trump becoming more friendly with India or any other trigger which can make those shorts get covered, this market is still a sell- on-rise and for Bank Nifty crucial levels, right now the support is at around 56,000 and we are closer to those levels. Once we break that, another 1,000, 1,500 point move on the downside can be till we cross 56,000 for Bank Nifty and 24,800 for Nifty, this will remain a sell-on- rise market.: These are great times for long-term investors to buy good stocks for their portfolios. Look at this quarter's results; where the results were good, but stock prices have gone nowhere, those are the stocks I would prefer to buy on every dip for my portfolio. One such stock is Paytm. I will accumulate Paytm at current market price and on dips to levels closer to 1,000 with a stop loss of Rs 970. I am also looking at targets of Rs 1,350-1,500 which can come over the next six months to one year. That will be a 30-50% rise from the current market stock which looks very strong to me, and where risk-reward is favouring a buy at current price is Nykaa. I am bullish on new age as a sector and Nykaa is a good buy at current market price and on dips to levels closer to 200, accumulate Nykaa for your portfolio, keep a stop loss of 190 and look at targets of Rs 245-250 to come from current market price.
Time of India
4 days ago
- Business
- Time of India
Biggest positive trigger for markets would be a sustainable resolution of tariff issue: Abhay Agarwal
Abhay Agarwal , Founder & Fund Manager, Piper Serica , says the markets are eagerly awaiting a resolution to the US president's tariff disputes, as the daily threats are impacting Indian industries. Order cancellations from US buyers in sectors like textiles and auto ancillaries are already occurring due to tariffs. A sustainable resolution is crucial to restore market confidence and prevent companies from withdrawing earnings guidance. What is your first comment on the RBI policy? I am sure it is on the expected lines. But given that inflation is going to be limited, and the tariff situation is still evolving, GDP for the current fiscal year has also not changed because of all the uncertainty that is looming around. Having said that, the situation is still evolving. We are also looking at a Fed policy. So, what is your take on the rate cut stance in India or the US, and the way ahead? Abhay Agarwal: The RBI policy was largely on expected lines but there were a couple of things that kind of differed from the past statements by the governor and one of them was the worry that the growth that they are seeing is uneven and I do not think as a governor he would want to see that or even the finance ministry would want to see that. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program One thing on their mind is how do we make sure that there is an even growth or largely even growth? The second is that the real inflation on the Street is higher than what the name plate inflation is showing and that is one of the reasons they want to see that play out over the next quarter or so, before deciding on the next rate cut. There is ample liquidity and that is the other thing that he indicated but what they want to see is that the rate transmission takes place right to the bottom of the pyramid which I do not think has taken place as per their expectations. So, for RBI, it is a work in process that it is not only just rate cuts that will drive the economic growth but also these impacts of rate cuts being felt by everybody, the borrowers and the industry kicking off of the private capex cycle. It is a wider agenda that he referred to and it will be interesting to see. The good thing from a market perspective is to see that the RBI is very focused on these key issues and will hopefully resolve them over the next three months and we will see the impact of that in the earnings in probably the third quarter this year. Live Events You Might Also Like: Take it one day at a time; not very bullish or very bearish at this point in time: Mihir Vora Now that we have all of these events, economic indicative actions, but still the triggers, the direction for the domestic market is missing. We see a lot of contingent scenarios from the global front, tariff implications are still underway and at the same time, the quarterly are a mixed bag. Where do you see the triggers coming in? What are the compounding themes? Abhay Agarwal: The markets are waiting for positive triggers and the biggest positive trigger is some kind of resolution to these tariff tantrums by the US president. This daily negative news flow, daily threats and it is something that people can discuss but completely out of control. Unfortunately, what I am seeing is that the impact of these tariffs are already being felt by the Indian industry. We have heard over the last couple of days, cancellation of orders by large US buyers from Indian suppliers in textiles, small auto ancillaries, and some consumer products because they do not want to pay that kind of tariff for imports from India. The Indian industry is already feeling the heat. It is not a discussion or a threat anymore. This has happened. The biggest positive trigger for the markets right now would be some kind of sustainable resolution of this daily tariff threat that has already started impacting Indian exporters and that will give the market confidence that the earnings can be forecast. Otherwise, most of the companies' management will pull out their management guidance for the next quarter and the quarter after that. It is very important that some kind of resolution comes into play.
Business Standard
7 days ago
- Health
- Business Standard
How Clinics On Cloud Is Building World's Largest Digital Healthcare Infrastructure?
VMPL New Delhi [India], August 4: While governments focus on building physical clinics like Ayushman Arogya Mandirs and healthcare service programs led by foundations such as Adani's Healthcare Temples to deliver essential care in underserved regions. Entrepreneur Mr. Abhay Agarwal Founder & CEO of Clinics On Cloud is building something just as impactful but digitally. It's turning healthcare into something you can access like an ATM. Clinics on Cloud's Health ATMs are transforming how primary healthcare is delivered automating what used to take hours in a hospital into 5-minute walk-ins. You don't need a hospital, a nurse, or even a waiting room. Vitals screenings, printed reports, and a real-time doctor consult all in one ATM. Just Like ATMs Changed Banking, Health ATM Changes Healthcare ATMs revolutionized banking by handling routine tasks, freeing up branches for more complex services. While a bank's main branch may be located in select areas, its ATMs are everywhere--automating everyday services for the masses. Clinics on Cloud applies the same principle to healthcare. While hospitals remain in urban centers, Health ATMs can be installed in underserved and remote areas to deliver primary care services. This not only decentralizes healthcare but also creates a seamless digital bridge between rural patients and urban medical infrastructure. A single Health ATM offers instant screenings, printed reports, and real-time doctor consultations--efficient, accessible, and built for everyone Why Digital Healthcare Alone Isn't Enough Digital healthcare sounds ideal--log in, consult a doctor, and get instant advice. But in reality, it often fails where it matters most: trust. "Patients don't feel confident when a doctor can't examine them. And doctors? They're left diagnosing in the dark," says Abhay Agarwal. Without real-time vitals like BP, sugar, oxygen, and temperature, virtual consultations become guesswork--no matter how good the tech is. This disconnect has led many well-funded Health tech startups to fail. Clinics on Cloud solves this with a hybrid model: patients visit a Health ATM, get guided by a trained operator, and consult with a doctor who sees live, accurate vitals. It's tech with trust--digital, but dependable. The Growing Health ATM Network Connecting 7+ Nations Clinics on Cloud has built a vast digital health network silently, strategically, and sustainably. With Health ATMs installed across India and seven other countries, the company is creating a borderless healthcare network that brings preventive care directly to the people This growth has been achieved while remaining entirely bootstrapped. Clinics on Cloud has scaled through partnerships with governments to reach underserved districts, through CSR collaborations to strengthen community health access, and through private organizations seeking reliable, decentralized healthcare delivery. Every Health ATM added to the network becomes part of a growing, intelligent ecosystem--digitally connected, real-time enabled, and built to bridge most critical healthcare gaps. (ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)
Economic Times
09-07-2025
- Business
- Economic Times
Abhay Agarwal's top sectoral bets in a choppy market
"I would say that our markets on a global scheme of things are still quite small. We are at $5 trillion market cap where you have companies in US which are close to $4 trillion market cap, single company. So, we are on that growth path. The foreign investors understand that. Obviously, these kind of uncertainties related to tariff situation and daily news-based announcements about US threatening to put new tariffs or taking out old tariffs is going to keep the markets on their toes in the short term, but in the longer term we are going to be pretty okay," says Abhay Agarwal, Piper Serica. ADVERTISEMENT And yes, there is a lot of development and developments happening overnight and the markets are mature enough at least Indian markets to digest all of that. But US President Donald Trump has now slapped tariffs ranging anywhere between 25% to 45% on several countries globally. Also, there is a very important statement which has come in where Trump says that he is very close to make a deal with India. How do you see all of these developments for the domestic markets? Abhay Agarwal: From domestic market perspective, I have just got back from a two-week trip to Europe and what I can tell you is that if you just move out of this noisy situation that we are in, as you just mentioned tariff related announcements and the global uncertainty around that, the good news is that India is seen as a bright spot of growth not only for the short term but for next 5 years 10 years. So, the good news is that there is a lot of foreign capital that is looking to come into India, invest in India for the long term. These are not short-term traders. The timing of the entry remains a question mark because there are worries about Indian markets being overvalued, but at the same time there is this belief that the market cap and the GDP growth will continue to inch up. So, I would say that our markets on a global scheme of things are still quite small. We are at $5 trillion market cap where you have companies in US which are close to $4 trillion market cap, single company. So, we are on that growth path. The foreign investors understand that. Obviously, these kind of uncertainties related to tariff situation and daily news-based announcements about US threatening to put new tariffs or taking out old tariffs is going to keep the markets on their toes in the short term, but in the longer term we are going to be pretty okay. So, your house is actually known for capitalising on market fear. Now, on those lines I just want to know what is the kind of cash holding that is present and you have been a fan of pharma since very long time. So, if we talk about key sectors which are on your radar and is pharma still a part of it and also a few pockets in BFSI, what is your take? Abhay Agarwal: So, right now, we are about 8% cash and we are not looking to increase cash holdings because we continue to see good opportunities in some sectors and even in a raging bull market there is always a bear market also going on in some sectors or some specific stocks because of various reasons. So, we would like to focus on those situations, those opportunities. We are seeing enough of them. So, our average cash holding is about 5% to 6% that we like to maintain. In terms of pharma, yes, for last two years we have seen a lot of recovery in pharma companies' earnings and that has been because of five years of solid investment by large pharma companies in their business, a very friendly US FDA that is trying to make bridges with India to make sure that India is a very solid supply chain partner for US pharmaceutical business. And also, the Indian companies overinvested to their credit in building a very strong list of new launches and some of the Indian companies like Dr Reddy's if you look at it, they have like 150 potential new launches over next 18 months in the US. ADVERTISEMENT So, the analysts have not given the Indian pharma companies enough credit. Hopefully that will reverse. But we are very hopeful that just like last year the pharma sector was the best performing sector amongst all sectors in last calendar year, we are expecting a similar performance this year and probably next year also because some of the spaces like CDMO are still emerging. So, we are very bullish on the pharma sector continuing to do well because of very strong tailwinds there. On banking and financial services, we are seeing recovery. I think the bottom has been made as far as NPA cycle, credit cycle was concerned, collections were concerned. The self-regulatory body of small finance banks and microfinance companies has done a good job of taking away the froth by building in the guardrails. So, we see recovery now in microfinance companies as well as small banks which are trying to become universal banks now. So, this is a sector that we are now overweight in. We were zero weight for last two years, but we have increased our weightage. So, these are the two sectors that we are quite bullish and the third one is EMS which is again a space that we expect to continue to do well. ADVERTISEMENT We are in an ambiguous state as far as trade deal is concerned. We do not know whether or not trade deal is happening or a mini deal is happening or a final deal will happen in next three to six months. In this scenario, what should one do? Should wait and watch, just sit on cash, or deploy money in sectors which may not be impacted by this. Abhay Agarwal: Yes, if you are an investor, you are sitting on cash and you have a buy list, it is a good strategy to keep nibbling in a systematic way and that is what we are also doing. All the new money that we are getting, we are not deploying it at one go. So, we have a buy list in form of our model portfolio. But what we are doing is we are averaging out the buying over next six months. ADVERTISEMENT The problem is that this is such a news-driven market and the news changes every day. The sentiment changes every day. Every half an hour there is a new announcement. My personal view is that India and US will conclude a trade deal. However, it will not be a kind of a final deal. It will have nuances. There will still be moving parts. There will still be sectors which will not be covered by this trade deal. So, there will not be 100% certainty for a long period of time. But even if you get to 50% certainty, it will be a good sign for the market. It will show intent from US and India both to conclude this deal. But it may take time. So, no country is going to back off easily. So, a good strategy for any investor sitting on cash would be to deploy over next six months in a systematic manner rather than doing it all at once. ADVERTISEMENT That conviction gives a lot of confidence and when you say to deploy money in a staggered manner and create a strategy yes, results and earning season is around the corner. So while we define and draw the strategy considering the result and earning season, what is your take, what all sectors should one keep an eye on and once we get an opportunity get into it? Abhay Agarwal: Overall, I am quite hopeful that this result season will be a good result season because we are coming off a smaller base and we are coming off two if not three result seasons which kind of were underwhelming, though the last one I would say was not underwhelming, it was probably neutral. But my expectation from the current earning season which is just going to start now is that, we will have some outperformance by companies that have turned their business model to take care of new product launches both in India as well as overseas. I am expecting better results from banking and financial services industry than analysts are expecting from pharmaceutical, from EMS companies, from insurance companies I am expecting positive guidance. But at the same time there are some sectors that will continue to drag a little. The leading one is IT services. We will see cautious commentary again and an underwhelming growth guidance from IT services industry. Also, from large FMCG companies, I am expecting that the numbers will not be good, the margins will still be under pressure, but the guidance will be better. Similar for auto industry, the numbers may underwhelm a little but the guidance will be pretty positive because we have had a good monsoon a pick-up in rural income, rural consumption. So, overall, I would say this result season will be good. I would also suggest to astute investor not to punt on results. Let the results come out. Even if there is a stock reaction, make use of it rather than pre-empting the result before it is announced.
Time of India
09-07-2025
- Business
- Time of India
Abhay Agarwal's top sectoral bets in a choppy market
"I would say that our markets on a global scheme of things are still quite small. We are at $5 trillion market cap where you have companies in US which are close to $4 trillion market cap, single company. So, we are on that growth path. The foreign investors understand that. Obviously, these kind of uncertainties related to tariff situation and daily news-based announcements about US threatening to put new tariffs or taking out old tariffs is going to keep the markets on their toes in the short term, but in the longer term we are going to be pretty okay," says Abhay Agarwal , Piper Serica . And yes, there is a lot of development and developments happening overnight and the markets are mature enough at least Indian markets to digest all of that. But US President Donald Trump has now slapped tariffs ranging anywhere between 25% to 45% on several countries globally. Also, there is a very important statement which has come in where Trump says that he is very close to make a deal with India. How do you see all of these developments for the domestic markets? Abhay Agarwal: From domestic market perspective, I have just got back from a two-week trip to Europe and what I can tell you is that if you just move out of this noisy situation that we are in, as you just mentioned tariff related announcements and the global uncertainty around that, the good news is that India is seen as a bright spot of growth not only for the short term but for next 5 years 10 years. So, the good news is that there is a lot of foreign capital that is looking to come into India, invest in India for the long term. These are not short-term traders. The timing of the entry remains a question mark because there are worries about Indian markets being overvalued, but at the same time there is this belief that the market cap and the GDP growth will continue to inch up. So, I would say that our markets on a global scheme of things are still quite small. We are at $5 trillion market cap where you have companies in US which are close to $4 trillion market cap, single company. So, we are on that growth path. The foreign investors understand that. Obviously, these kind of uncertainties related to tariff situation and daily news-based announcements about US threatening to put new tariffs or taking out old tariffs is going to keep the markets on their toes in the short term, but in the longer term we are going to be pretty okay. So, your house is actually known for capitalising on market fear. Now, on those lines I just want to know what is the kind of cash holding that is present and you have been a fan of pharma since very long time. So, if we talk about key sectors which are on your radar and is pharma still a part of it and also a few pockets in BFSI , what is your take? Abhay Agarwal: So, right now, we are about 8% cash and we are not looking to increase cash holdings because we continue to see good opportunities in some sectors and even in a raging bull market there is always a bear market also going on in some sectors or some specific stocks because of various reasons. Live Events So, we would like to focus on those situations, those opportunities. We are seeing enough of them. So, our average cash holding is about 5% to 6% that we like to maintain. In terms of pharma, yes, for last two years we have seen a lot of recovery in pharma companies' earnings and that has been because of five years of solid investment by large pharma companies in their business, a very friendly US FDA that is trying to make bridges with India to make sure that India is a very solid supply chain partner for US pharmaceutical business. And also, the Indian companies overinvested to their credit in building a very strong list of new launches and some of the Indian companies like Dr Reddy's if you look at it, they have like 150 potential new launches over next 18 months in the US. So, the analysts have not given the Indian pharma companies enough credit. Hopefully that will reverse. But we are very hopeful that just like last year the pharma sector was the best performing sector amongst all sectors in last calendar year, we are expecting a similar performance this year and probably next year also because some of the spaces like CDMO are still emerging. So, we are very bullish on the pharma sector continuing to do well because of very strong tailwinds there. On banking and financial services, we are seeing recovery. I think the bottom has been made as far as NPA cycle, credit cycle was concerned, collections were concerned. The self-regulatory body of small finance banks and microfinance companies has done a good job of taking away the froth by building in the guardrails. So, we see recovery now in microfinance companies as well as small banks which are trying to become universal banks now. So, this is a sector that we are now overweight in. We were zero weight for last two years, but we have increased our weightage. So, these are the two sectors that we are quite bullish and the third one is EMS which is again a space that we expect to continue to do well. We are in an ambiguous state as far as trade deal is concerned. We do not know whether or not trade deal is happening or a mini deal is happening or a final deal will happen in next three to six months. In this scenario, what should one do? Should wait and watch, just sit on cash, or deploy money in sectors which may not be impacted by this. Abhay Agarwal: Yes, if you are an investor, you are sitting on cash and you have a buy list, it is a good strategy to keep nibbling in a systematic way and that is what we are also doing. All the new money that we are getting, we are not deploying it at one go. So, we have a buy list in form of our model portfolio. But what we are doing is we are averaging out the buying over next six months. The problem is that this is such a news-driven market and the news changes every day. The sentiment changes every day. Every half an hour there is a new announcement. My personal view is that India and US will conclude a trade deal. However, it will not be a kind of a final deal. It will have nuances. There will still be moving parts. There will still be sectors which will not be covered by this trade deal. So, there will not be 100% certainty for a long period of time. But even if you get to 50% certainty, it will be a good sign for the market. It will show intent from US and India both to conclude this deal. But it may take time. So, no country is going to back off easily. So, a good strategy for any investor sitting on cash would be to deploy over next six months in a systematic manner rather than doing it all at once. That conviction gives a lot of confidence and when you say to deploy money in a staggered manner and create a strategy yes, results and earning season is around the corner. So while we define and draw the strategy considering the result and earning season, what is your take, what all sectors should one keep an eye on and once we get an opportunity get into it? Abhay Agarwal: Overall, I am quite hopeful that this result season will be a good result season because we are coming off a smaller base and we are coming off two if not three result seasons which kind of were underwhelming, though the last one I would say was not underwhelming, it was probably neutral. But my expectation from the current earning season which is just going to start now is that, we will have some outperformance by companies that have turned their business model to take care of new product launches both in India as well as overseas. I am expecting better results from banking and financial services industry than analysts are expecting from pharmaceutical, from EMS companies, from insurance companies I am expecting positive guidance. But at the same time there are some sectors that will continue to drag a little. The leading one is IT services. We will see cautious commentary again and an underwhelming growth guidance from IT services industry. Also, from large FMCG companies, I am expecting that the numbers will not be good, the margins will still be under pressure, but the guidance will be better. Similar for auto industry, the numbers may underwhelm a little but the guidance will be pretty positive because we have had a good monsoon a pick-up in rural income, rural consumption. So, overall, I would say this result season will be good. I would also suggest to astute investor not to punt on results. Let the results come out. Even if there is a stock reaction, make use of it rather than pre-empting the result before it is announced. ETMarkets WhatsApp channel )
